Skip to content
Riskpilot
← Back to search
Sign in
Get full access
MittVaccin Sverige AB
AB
Active
Org 5568833411
Drottninggatan 89, 113 60
Stockholm
Engineering activities and related technical consultancy
· NACE 7112
Est. 2012
10 employees
Watchlist
Share
Sweden
/
Companies
/
Engineering activities and related technical consultancy
/
MittVaccin Sverige AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
10M
20M
30M
40M
5M
2020
28M
2021
24M
2022
35M
2023
35M
2024
EBITDA
SEK millions
0M
3M
7M
10M
14M
-2M
2020
4M
2021
5M
2022
12M
2023
10M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
4 776
27 929
24 390
35 154
34 961
Staff expenses
—
—
—
—
—
EBITDA
−2 383
4 480
4 626
12 336
10 082
Depreciation & amort.
−1 307
−2 007
−2 072
−2 072
−49
EBIT
−3 690
2 473
2 554
10 264
10 033
Net financials
−29
−165
−230
−296
−619
Profit before tax
−3 720
2 308
387
−328
−635
Tax
629
−478
−0
−0
−151
Net profit
−3 091
1 830
387
−328
−786
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
8 386
14 945
28 659
39 635
38 049
Equity
1 945
3 775
4 162
3 834
3 048
Long-term debt
4 212
7 456
9 810
20 526
31 356
Short-term debt
2 229
3 714
14 687
15 275
3 645
Total debt
6 441
11 170
24 497
35 801
35 001
Financial ratios
5-year trend
EBITDA margin
28.8%
This company
15.8%
Market median
+82% vs market
2020
2024
Equity ratio
8.0%
This company
38.2%
Market median
-79% vs market
2020
2024
Return on equity
-25.8%
This company
18.4%
Market median
-240% vs market
2020
2024
Net profit margin
-2.2%
This company
8.1%
Market median
-127% vs market
2020
2024
Asset turnover
0.92×
This company
1.12×
Market median
+18% vs market
2020
2024
Debt / equity
11.48×
This company
0.62×
Market median
-1752% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on MittVaccin Sverige AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
